Acceso usuarios
Diane S. Aschenbrenner
* A new combination antibiotic has been approved to treat complicated intraabdominal and urinary tract infections. The drug, sold under the trade name Avycaz, pairs ceftazidime, a cephalosporin, with a new beta-lactamase inhibitor, avibactam.
